Homodimerization controls the fibroblast growth factor 9 subfamily's receptor binding and heparan sulfate-dependent diffusion in the extracellular matrix

Molecular and Cellular Biology

Volumn 29, Issue 17, 2009, Pages 4663-4678

  Kalinina, Juliya ^a   Byron, Sara A ^b   Makarenkova, Helen P ^c,d   Olsen, Shaun K ^a,h   Eliseenkova, Anna V ^a   Larochelle, William J ^e,i   Dhanabal, Mohanraj ^e,j   Blais, Steven ^a   Ornitz, David M ^g   Day, Loren A ^f   Neubert, Thomas A ^a   Pollock, Pamela M ^b   Mohammadi, Moosa ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TRANSLATIONAL GENOMICS RESEARCH INSTITUTE   (United States)

^c SCRIPPS RESEARCH INSTITUTE   (United States)

^d NEUROSCIENCES INSTITUTE   (United States)

^e CURAGEN CORPORATION   (United States)

^f PUBLIC HEALTH RESEARCH INSTITUTE   (United States)

^g WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

ⁱ 454 Life Sciences Corporation   (United States)

^j EMD SERONO INC   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 20; FIBROBLAST GROWTH FACTOR 9; HEPARAN SULFATE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BINDING SITE; DIMERIZATION; EMBRYO; EXTRACELLULAR MATRIX; GENE MUTATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR BINDING;

AMINO ACID SEQUENCE; ANIMALS; CELLS, CULTURED; CRYSTALLOGRAPHY, X-RAY; DIFFUSION; DIMERIZATION; EXTRACELLULAR MATRIX; FEMALE; FIBROBLAST GROWTH FACTOR 9; FIBROBLAST GROWTH FACTORS; HEPARITIN SULFATE; HUMANS; LIGANDS; MICE; MICE, INBRED C57BL; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MUTATION; PREGNANCY; PROTEIN MULTIMERIZATION; PROTEIN STRUCTURE, QUATERNARY; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 1; SIGNAL TRANSDUCTION;

EID: 68849110534     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.01780-08     Document Type: Article

References (71)

1. Alvarez, E., E. G. Fey, P. Valax, Z. Yim, J. D. Peterson, M. Mesri, M. Jeffers, M. Dindinger, N. Twomlow, A. Ghatpande, W. J. LaRochelle, S. T. Sonis, and H. S. Lichenstein. 2003. Preclinical characterization of CG53135 (FGF-20) in radiation and concomitant chemotherapy/radiation-induced oral mucositis. Clin. Cancer Res. 9:3454-3461.
2. Ara, G., B. A. Watkins, H. Zhong, T. R. Hawthorne, C. E. Karkaria, S. T. Sonis, and W. J. Larochelle. 2008. Velafermin (rhFGF-20) reduces the severity and duration of hamster cheek pouch mucositis induced by fractionated radiation. Int. J. Radiat. Biol. 84:401-412.
3. Bottcher, R. T., and C. Niehrs. 2005. Fibroblast growth factor signaling during early vertebrate development. Endocr. Rev. 26:63-77.
4. Brunger, A. T., P. D. Adams, G. M. Clore, W. L. DeLano, P. Gros, R. W. Grosse-Kunstleve, J.-S. Jiang, J. Kuszewski, M. Nilges, N. S. Pannu, R. J. Read, L. M. Rice, T. Simonson, and G. L. Warren. 1998. Crystallography & NMR system: a new software suite for macromolecular structure determination. Acta Crystallogr. D 54:905-921.
5. Chen, H., J. Ma, W. Li, A. V. Eliseenkova, C. Xu, T. A. Neubert, W. T. Miller, and M. Mohammadi. 2007. A molecular brake in the kinase hinge region regulates the activity of receptor tyrosine kinases. Mol. Cell 27:717-730.
6. Cho, H. S., and D. J. Leahy. 2002. Structure of the extracellular region of HER3 reveals an interdomain tether. Science 297:1330-1333.
7. Colvin, J. S., A. C. White, S. J. Pratt, and D. M. Ornitz. 2001. Lung hypoplasia and neonatal death in Fgf9-null mice identify this gene as an essential regulator of lung mesenchyme. Development 128:2095-2106.
8. del Moral, P. M., S. P. De Langhe, F. G. Sala, J. M. Veltmaat, D. Tefft, K. Wang, D. Warburton, and S. Bellusci. 2006. Differential role of FGF9 on epithelium and mesenchyme in mouse embryonic lung. Dev. Biol. 293:77-89.
9. Dill, K. A. 1985. Theory for the folding and stability of globular proteins. Biochemistry 24:1501-1509.
10. Evans, S. J., P. V. Choudary, C. R. Neal, J. Z. Li, M. P. Vawter, H. Tomita, J. F. Lopez, R. C. Thompson, F. Meng, J. D. Stead, D. M. Walsh, R. M. Myers, W. E. Bunney, S. J. Watson, E. G. Jones, and H. Akil. 2004. Dysregulation of the fibroblast growth factor system in major depression. Proc. Natl. Acad. Sci. USA 101:15506-15511.
11. Faham, S., R. J. Linhardt, and D. C. Rees. 1998. Diversity does make a difference: fibroblast growth factor-heparin interactions. Curr. Opin. Struct. Biol. 8:578-586.
12. Ferguson, K. M., M. B. Berger, J. M. Mendrola, H. S. Cho, D. J. Leahy, and M. A. Lemmon. 2003. EGF activates its receptor by removing interactions that autoinhibit ectodomain dimerization. Mol. Cell 11:507-517.
13. Gartside, M. G., H. Chen, O. A. Ibrahimi, S. A. Byron, A. V. Curtis, C. L. Wellens, A. Bengston, L. M. Yudt, A. V. Eliseenkova, J. Ma, J. A. Curtin, P. Hyder, U. L. Harper, E. Riedesel, G. J. Mann, J. M. Trent, B. C. Bastian, P. S. Meltzer, M. Mohammadi, and P. M. Pollock. 2009. Loss-of-function fibroblast growth factor receptor-2 mutations in melanoma. Mol. Cancer Res. 7:41-54.
14. Geske, M. J., X. Zhang, K. K. Patel, D. M. Ornitz, and T. S. Stappenbeck. 2008. Fgf9 signaling regulates small intestinal elongation and mesenchymal development. Development 135:2959-2968.
15. Goetz, R., A. Beenken, O. A. Ibrahimi, J. Kalinina, S. K. Olsen, A. V. Eliseenkova, C. Xu, T. A. Neubert, F. Zhang, R. J. Linhardt, X. Yu, K. E. White, T. Inagaki, S. A. Kliewer, M. Yamamoto, H. Kurosu, Y. Ogawa, M. Kuro-o, B. Lanske, M. S. Razzaque, and M. Mohammadi. 2007. Molecular insights into the klotho-dependent, endocrine mode of action of fibroblast growth factor 19 subfamily members. Mol. Cell. Biol. 27:3417-3428.
16. Grose, R., and C. Dickson. 2005. Fibroblast growth factor signaling in tumorigenesis. Cytokine Growth Factor Rev. 16:179-186.
17. Harada, M., H. Murakami, A. Okawa, N. Okimoto, S. Hiraoka, T. Nakahara, R. Akasaka, Y. Shiraishi, N. Futatsugi, Y. Mizutani-Koseki, A. Kuroiwa, M. Shirouzu, S. Yokoyama, M. Taiji, S. Iseki, D. M. Ornitz, and H. Koseki. 2009. FGF9 monomer-dimer equilibrium regulates extracellular matrix affinity and tissue diffusion. Nat. Genet. 41:289-298.
18. Harmer, N. J. 2006. Insights into the role of heparan sulphate in fibroblast growth factor signalling. Biochem. Soc. Trans. 34:442-445.
19. Hogan, B. L., and J. M. Yingling. 1998. Epithelial/mesenchymal interactions and branching morphogenesis of the lung. Curr. Opin. Genet. Dev. 8:481-486.
20. Hou, J., M. Kan, F. Wang, J. M. Xu, M. Nakahara, G. McBride, K. McKeehan, and W. L. McKeehan. 1992. Substitution of putative half-cystine residues in heparin-binding fibroblast growth factor receptors. Loss of binding activity in both two and three loop isoforms. J. Biol. Chem. 267:17804-17808.
21. Hubbard, S. R. 2004. Juxtamembrane autoinhibition in receptor tyrosine kinases. Nat. Rev. Mol. Cell Biol. 5:464-471.
22. Ibrahimi, O. A., F. Zhang, A. V. Eliseenkova, N. Itoh, R. J. Linhardt, and M. Mohammadi. 2004. Biochemical analysis of pathogenic ligand-dependent FGFR2 mutations suggests distinct pathophysiological mechanisms for craniofacial and limb abnormalities. Hum. Mol. Genet. 13:2313-2324.
23. Inagaki, T., M. Choi, A. Moschetta, L. Peng, C. L. Cummins, J. G. McDonald, G. Luo, S. A. Jones, B. Goodwin, J. A. Richardson, R. D. Gerard, J. J. Repa, D. J. Mangelsdorf, and S. A. Kliewer. 2005. Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis. Cell Metab. 2:217-225.
24. Iseki, S., A. O. Wilkie, J. K. Heath, T. Ishimaru, K. Eto, and G. M. Morriss-Kay. 1997. Fgfr2 and osteopontin domains in the developing skull vault are mutually exclusive and can be altered by locally applied FGF2. Development 124:3375-3384.
25. Jin, C., F. Wang, X. Wu, C. Yu, Y. Luo, and W. L. McKeehan. 2004. Directionally specific paracrine communication mediated by epithelial FGF9 to stromal FGFR3 in two-compartment premalignant prostate tumors. Cancer Res. 64:4555-4562.
26. Jones, T. A., J. Y. Zou, S. W. Cowan, and M. Kjeldgaard. 1991. Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Crystallogr. A 47:110-119.
27. Kharitonenkov, A., T. L. Shiyanova, A. Koester, A. M. Ford, R. Micanovic, E. J. Galbreath, G. E. Sandusky, L. J. Hammond, J. S. Moyers, R. A. Owens, J. Gromada, J. T. Brozinick, E. D. Hawkins, V. J. Wroblewski, D. S. Li, F. Mehrbod, S. R. Jaskunas, and A. B. Shanafelt. 2005. FGF-21 as a novel metabolic regulator. J. Clin. Investig. 115:1627-1635.
28. Kuro-o, M. 2008. Endocrine FGFs and klothos: emerging concepts. Trends Endocrinol. Metab. 19:239-245.
29. Kuslak, S. L., J. L. Thielen, and P. C. Marker. 2007. The mouse seminal vesicle shape mutation is allelic with Fgfr2. Development 134:557-565.
30. Lalla, R. V. 2005. Velafermin (CuraGen). Curr. Opin. Investig. Drugs 6:1179-1185.
31. Lavine, K. J., A. C. White, C. Park, C. S. Smith, K. Choi, F. Long, C. C. Hui, and D. M. Ornitz. 2006. Fibroblast growth factor signals regulate a wave of Hedgehog activation that is essential for coronary vascular development. Genes Dev. 20:1651-1666.
32. Lavine, K. J., K. Yu, A. C. White, X. Zhang, C. Smith, J. Partanen, and D. M. Ornitz. 2005. Endocardial and epicardial derived FGF signals regulate myocardial proliferation and differentiation in vivo. Dev. Cell 8:85-95.
33. Lawrence, M. C., and P. M. Colman. 1993. Shape complementarity at protein/ protein interfaces. J. Mol. Biol. 234:946-950.
34. Maclachlan, T., B. Narayanan, V. L. Gerlach, G. Smithson, R. W. Gerwien, O. Folkerts, E. G. Fey, B. Watkins, T. Seed, and E. Alvarez. 2005. Human fibroblast growth factor 20 (FGF-20; CG53135-05): a novel cytoprotectant with radioprotective potential. Int. J. Radiat. Biol. 81:567-579.
35. Mailleux, A. A., B. Spencer-Dene, C. Dillon, D. Ndiaye, C. Savona-Baron, N. Itoh, S. Kato, C. Dickson, J. P. Thiery, and S. Bellusci. 2002. Role of FGF10/FGFR2b signaling during mammary gland development in the mouse embryo. Development 129:53-60.
36. Makarenkova, H. P., M. Ito, V. Govindarajan, S. C. Faber, L. Sun, G. McMahon, P. A. Overbeek, and R. A. Lang. 2000. FGF10 is an inducer and Pax6 a competence factor for lacrimal gland development. Development 127:2563-2572.
37. Mohammadi, M., S. K. Olsen, and R. Goetz. 2005. A protein canyon in the FGF-FGF receptor dimer selects from an a la carte menu of heparan sulfate motifs. Curr. Opin. Struct. Biol. 15:506-516.
38. Mohammadi, M., S. K. Olsen, and O. A. Ibrahimi. 2005. Structural basis for fibroblast growth factor receptor activation. Cytokine Growth Factor Rev. 16:107-137.
39. Murzin, A. G., A. M. Lesk, and C. Chothia. 1992. beta-Trefoil fold. Patterns of structure and sequence in the Kunitz inhibitors interleukins-1 beta and 1 alpha and fibroblast growth factors. J. Mol. Biol. 223:531-543.
40. Navaza, J. 1994. AMoRe: an automated package for molecular replacement. Acta Crystallogr. A 50:157-163.
41. Nomura, R., E. Kamei, Y. Hotta, M. Konishi, A. Miyake, and N. Itoh. 2006. Fgf16 is essential for pectoral fin bud formation in zebrafish. Biochem. Biophys. Res. Commun. 347:340-346.
42. Ohmachi, S., T. Mikami, M. Konishi, A. Miyake, and N. Itoh. 2003. Preferential neurotrophic activity of fibroblast growth factor-20 for dopaminergic neurons through fibroblast growth factor receptor-1c. J. Neurosci. Res. 72: 436-443.
43. Ohmachi, S., Y. Watanabe, T. Mikami, N. Kusu, T. Ibi, A. Akaike, and N. Itoh. 2000. FGF-20, a novel neurotrophic factor, preferentially expressed in the substantia nigra pars compacta of rat brain. Biochem. Biophys. Res. Commun. 277:355-360.
44. Olsen, S. K., O. A. Ibrahimi, A. Raucci, F. Zhang, A. V. Eliseenkova, A. Yayon, C. Basilico, R. J. Linhardt, J. Schlessinger, and M. Mohammadi. 2004. Insights into the molecular basis for fibroblast growth factor receptor autoinhibition and ligand-binding promiscuity. Proc. Natl. Acad. Sci. USA 101:935-940.
45. Ornitz, D. M., and N. Itoh. 2001. Fibroblast growth factors. Genome Biol. 2:REVIEWS3005.
46. Ornitz, D. M., J. Xu, J. S. Colvin, D. G. McEwen, C. A. MacArthur, F. Coulier, G. Gao, and M. Goldfarb. 1996. Receptor specificity of the fibroblast growth factor family. J. Biol. Chem. 271:15292-15297.
47. Orr-Urtreger, A., M. T. Bedford, T. Burakova, E. Arman, Y. Zimmer, A. Yayon, D. Givol, and P. Lonai. 1993. Developmental localization of the splicing alternatives of fibroblast growth factor receptor-2 (FGFR2). Dev. Biol. 158:475-486.
48. Otwinowski, Z., and W. Minor. 1997. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 276:307-326.
49. Pirvola, U., X. Zhang, J. Mantela, D. M. Ornitz, and J. Ylikoski. 2004. Fgf9 signaling regulates inner ear morphogenesis through epithelial-mesenchymal interactions. Dev. Biol. 273:350-360.
50. Plotnikov, A. N., A. V. Eliseenkova, O. A. Ibrahimi, Z. Shriver, R. Sasisekharan, M. A. Lemmon, and M. Mohammadi. 2001. Crystal structure of fibroblast growth factor 9 reveals regions implicated in dimerization and autoinhibition. J. Biol. Chem. 276:4322-4329.
51. Plotnikov, A. N., S. R. Hubbard, J. Schlessinger, and M. Mohammadi. 2000. Crystal structures of two FGF-FGFR complexes reveal the determinants of ligand-receptor specificity. Cell 101:413-424.
52. Plotnikov, A. N., J. Schlessinger, S. R. Hubbard, and M. Mohammadi. 1999. Structural basis for FGF receptor dimerization and activation. Cell 98:641-650.
53. Rapraeger, A. C., A. Krufka, and B. B. Olwin. 1991. Requirement of heparan sulfate for bFGF-mediated fibroblast growth and myoblast differentiation. Science 252:1705-1708.
54. Sanchez-Pernaute, R., H. Lee, M. Patterson, C. Reske-Nielsen, T. Yoshizaki, K. C. Sonntag, L. Studer, and O. Isacson. 2008. Parthenogenetic dopamine neurons from primate embryonic stem cells restore function in experimental Parkinson's disease. Brain 131:2127-2139.
55. Schlessinger, J., A. N. Plotnikov, O. A. Ibrahimi, A. V. Eliseenkova, B. K. Yeh, A. Yayon, R. J. Linhardt, and M. Mohammadi. 2000. Crystal structure of a ternary FGF-FGFR-heparin complex reveals a dual role for heparin in FGFR binding and dimerization. Mol. Cell 6:743-750.
56. Schuck, P. 2003. On the analysis of protein self-association by sedimentation velocity analytical ultracentrifugation. Anal. Biochem. 320:104-124.
57. Shimada, T., M. Kakitani, Y. Yamazaki, H. Hasegawa, Y. Takeuchi, T. Fujita, S. Fukumoto, K. Tomizuka, and T. Yamashita. 2004. Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism. J. Clin. Investig. 113:561-568.
58. Stauber, D. J., A. D. DiGabriele, and W. A. Hendrickson. 2000. Structural interactions of fibroblast growth factor receptor with its ligands. Proc. Natl. Acad. Sci. USA 97:49-54.
59. Steinberg, Z., C. Myers, V. M. Heim, C. A. Lathrop, I. T. Rebustini, J. S. Stewart, M. Larsen, and M. P. Hoffman. 2005. FGFR2b signaling regulates ex vivo submandibular gland epithelial cell proliferation and branching morphogenesis. Development 132:1223-1234.
60. Su, N., X. Du, and L. Chen. 2008. FGF signaling: its role in bone development and human skeleton diseases. Front. Biosci. 13:2842-2865.
61. Takagi, Y., J. Takahashi, H. Saiki, A. Morizane, T. Hayashi, Y. Kishi, H. Fukuda, Y. Okamoto, M. Koyanagi, M. Ideguchi, H. Hayashi, T. Imazato, H. Kawasaki, H. Suemori, S. Omachi, H. Iida, N. Itoh, N. Nakatsuji, Y. Sasai, and N. Hashimoto. 2005. Dopaminergic neurons generated from monkey embryonic stem cells function in a Parkinson primate model. J. Clin. Investig. 115:102-109.
62. Thisse, B., and C. Thisse. 2005. Functions and regulations of fibroblast growth factor signaling during embryonic development. Dev. Biol. 287:390-402.
63. Turner, C. A., N. Calvo, D. O. Frost, H. Akil, and S. J. Watson. 2008. The fibroblast growth factor system is downregulated following social defeat. Neurosci. Lett. 430:147-150.
64. van der Walt, J. M., M. A. Noureddine, R. Kittappa, M. A. Hauser, W. K. Scott, R. McKay, F. Zhang, J. M. Stajich, K. Fujiwara, B. L. Scott, M. A. Pericak-Vance, J. M. Vance, and E. R. Martin. 2004. Fibroblast growth factor 20 polymorphisms and haplotypes strongly influence risk of Parkinson disease. Am. J. Hum. Genet. 74:1121-1127.
65. White, A. C., J. Xu, Y. Yin, C. Smith, G. Schmid, and D. M. Ornitz. 2006. FGF9 and SHH signaling coordinate lung growth and development through regulation of distinct mesenchymal domains. Development 133:1507-1517.
66. Whitehead, G. G., S. Makino, C. L. Lien, and M. T. Keating. 2005. fgf20 is essential for initiating zebrafish fin regeneration. Science 310:1957-1960.
67. Wilkie, A. O. 2005. Bad bones, absent smell, selfish testes: the pleiotropic consequences of human FGF receptor mutations. Cytokine Growth Factor Rev. 16:187-203.
68. Xu, X., M. Weinstein, C. Li, M. Naski, R. I. Cohen, D. M. Ornitz, P. Leder, and C. Deng. 1998. Fibroblast growth factor receptor 2 (FGFR2)-mediated reciprocal regulation loop between FGF8 and FGF10 is essential for limb induction. Development 125:753-765.
69. Yayon, A., M. Klagsbrun, J. D. Esko, P. Leder, and D. M. Ornitz. 1991. Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor. Cell 64:841-848.
70. Yeh, B. K., M. Igarashi, A. V. Eliseenkova, A. N. Plotnikov, I. Sher, D. Ron, S. A. Aaronson, and M. Mohammadi. 2003. Structural basis by which alternative splicing confers specificity in fibroblast growth factor receptors. Proc. Natl. Acad. Sci. USA 100:2266-2271.
71. Zhang, X., T. S. Stappenbeck, A. C. White, K. J. Lavine, J. I. Gordon, and D. M. Ornitz. 2006. Reciprocal epithelial-mesenchymal FGF signaling is required for cecal development. Development 133:173-180.